Cypex - in vitro drug metabolism systems
Cypex - in vitro drug metabolism systems
Cypex - in vitro drug metabolism systemsproducts and services

Cypex - in vitro drug metabolism systemsabout us

Cypex - in vitro drug metabolism systemslatest news

Cypex - in vitro drug metabolism systemsdata sheets
Cypex - in vitro drug metabolism systemspublications
Cypex - in vitro drug metabolism systemsfrequently asked questions
Cypex - in vitro drug metabolism systemsassays
Cypex - in vitro drug metabolism systemscontact us
linksCypex - in vitro drug metabolism systems
Cypex - in vitro drug metabolism systems
bio-dundee logoscottish enterprise biotech
products and services
 

Cypex SULT2A1 QC Assay

Activity: 17beta-estradiol sulfotransferase (3-sulfate formation)

Incubation conditions
Assay buffer: 0.05 M potassium phosphate pH 7.4, 5 mM MgCl2, 10 mM dithiothreitol
Incubation volume: 200 µl
Stop reagent: 1 M hydrochloric acid (10 µl)

HPLC conditions
Column: HyperClone ODS (5 µm) 250 x 4 mm
Temperature: 40
°C
Mobile phase: (isocratic)
    41% Water
    45% Acetonitrile
    14% 50 mM ammonium acetate/50 mM tetrabutylammonium (pH 3.6)
Flow rate: 1.0 ml/min
Run time: 9.5 min
Injection volume: 100 µl
Detection: fluorescence
l(ex) = 211 nm, l(em) = 312 nm
Retention times:

       17beta-estradiol 17-sulfate    3.9 min
     17beta-estradiol 3-sulfate      4.4 min
     17beta-estradiol                   5.5 min

 

Important: By purchasing this product from Cypex you accept the standard terms and conditions of supply, details of which may be provided upon request.

United States Patent Nos. 4,952,496, 5,693,489 and 5,869,320.

PRODUCTS & SERVICES | ABOUT US | LATEST NEWS | DATA SHEETS | PUBLICATIONS | FAQ'S | ASSAYS | CONTACT US | LINKS | INTRO | TERMS | HOME
Designed and created by Rob Cook at Limehouse Design